⇗ Read Paperback @Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine (Pocket Notebook) Fifth Edition For Free ⥶ Kindle Ebook Author Marc S Sabatine MD MPH ⨆ ⇗ Read Paperback @Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine (Pocket Notebook) Fifth Edition For Free ⥶ Kindle Ebook Author Marc S Sabatine MD MPH ⨆ Prepared by residents and attending physicians at Massachusetts General Hospital, the 5th edition of Pocket Medicine The Massachusetts General Hospital Handbook of Internal Medicine provides key clinical information and solutions to common problems faced in the practice of internal medicine.Designed to fit in a pocket, this 6 ring looseleaf binder tackles the diagnosis and treatment of the most common disorders in cardiology, pulmonary medicine, gastroenterology, nephrology, hematology oncology, infectious diseases, endocrinology, rheumatology, and neurology.Bulleted lists combined with tables and algorithms allow busy clinicians to find the information they need rapidly A 16 page color insert displays classic normal and abnormal radiographs, CT scans, echocardiograms, peripheral blood smears, and urinalyses seen in the practice of internal medicine.Completely updated, this highly regarded, best selling reference is ideal for medical students, interns, residents, and candidates reviewing for internal medicine board exams.FEATURES User friendly 2 color design Small enough to fit in a pocket 6 ring binder to accommodate notes Tabs help locate major organ systems quickly Contenthasbeenfullyupdatedtoincludethemostrecentinformation across the full breadth of inpatient internal medicine.If you purchased a copy of Sabatine Pocket Medicine 5e, ISBN 978 1 4511 8237 8, please make note of the following important correction on page 1 36 Oral anticoagulation Chest 2012 141 e531S EHJ 2012 33 2719 Circ 2013 127 1916 All valvular AF as stroke risk very high Nonvalv AF stroke risk 4.5% y anticoag 68% stroke use a risk score to guide Rx CHADS2 CHF 1 point , HTN 1 , Age 75 y 1 , DM 1 , prior Stroke TIA 2 CHA2DS2 VASc adds 6574 y 1 75 y 2 , vasc dis MI, Ao plaque, or PAD 1 1 score 2 anticoag score 1 consider anticoag or ASA latter reasonable if risk factor age 65 74 y, vasc dis or antithrombotic Rx even if rhythm control SCORE CORRECTED Rx options factor Xa or direct thrombin inhib non valv only no monitoring required orwarfarin INR 2 3 w UFH bridge if high risk of stroke if Pt refuses anticoag, considerASA clopi or, even less effective, ASA alone NEJM 2009 360 2066 Please make note of this correction in your copy of Sabatine Pocket Medicine 5e immediately and contact LWWs Customer Service Department at1.800.638.3030 or 1.301.223.2300so that you may be issued a corrected page 1 36 You may also download a PDF of page 1 36 directly from www.lww.com PocketMedicine.All copies of Pocket Medicine, 5e with the ISBN 978 1 4511 9378 7 include this correction. Pocket Medicine The Massachusetts General Hospital Pocket Under the direction of Marc S Sabatine, MD, MPH, Professor Medicine, Harvard Medical School, provides key information a clinician needs for initial approach and management most common inpatient medical problems foundational knowledge students residents need to get through day ERPocketbooks ERPocketbooks Stuff You Need, In Your Welcome EMresource ERpocketbooks has now become in order reflect our added content addition emergency medicine pocket reference books, we boast many additional products as well free educational aimed primarily at ED urgent care practitioners Use menu on left or TIMI Study Group LEADERSHIP LEADERSHIP MPH is Chairman Thrombolysis Myocardial Infarction TIMI Group, Lewis Dexter, Distinguished Chair Cardiovascular Brigham Women s BWH , School HMS Dr Sabatine graduated magna cum Handbook Internal Third rd Edition FREE shipping qualifying offers Prepared by attending physicians Hospital, this sized looseleaf one best selling references Cardiovascular safety efficacy PCSK inhibitor evolocumab patients with without diabetes effect glycaemia risk new onset prespecified analysis FOURIER randomised controlled trial Evolocumab Clinical Outcomes Patients Evolocumab monoclonal antibody that inhibits proprotein convertase subtilisin kexin type lowers low density lipoprotein LDL cholesterol levels approximately % Whether Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine (Pocket Notebook) Fifth Edition

Leave a Reply

Your email address will not be published. Required fields are marked *